Genomic Health Reports Favorable Commentary on Value of Multigene Assays From the St. Gallen Expert Consensus Meeting on the Primary Treatment of Early Breast Cancer
- Guidelines Specify that Validated Molecular Assays Should be Considered as an Adjunct to Standard Measures in Helping Determine Chemotherapy Benefit -
GENEVA, and REDWOOD CITY, Calif., June 26 /PRNewswire-FirstCall/ -- Genomic Health, Inc. (Nasdaq: GHDX ) today reported that the St. Galle...
Scientists identify gene vital to early embryonic cells forming a normal heart and skull
New research from Cincinnati Children's Hospital Medical Center highlights the critical role a certain gene and its protein play during early
embryonic development on formation of a normal heart and skull.
In a study posted online June 15 by the Proceedings of the National Academy of Sciences ...
Debiopharm Group and Moffitt Cancer Center Sign Development and Commercialisation Agreement for Small Molecule Debio 0928 in Early Preclinical Development for Treatment of Solid Tumours
LAUSANNE, Switzerland and TAMPA, Florida, June 18 /PRNewswire/ --
Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group
of companies with a focus on the development of prescription drugs that
target unmet medical needs, and Moffitt Cancer Center (Moffitt), a non-profit
LNA-Based HIF-1 Alpha Inhibitor Shows Early Signs of Clinical Benefit
COPENHAGEN, June 4 /PRNewswire/ -- Santaris Pharma today announced that
the cancer drug EZN-2968 - an inhibitor of HIF-1alpha, jointly developed by
Enzon Pharmaceuticals and Santaris Pharma A/S - was well tolerated and showed
early signs of clinical benefit in previously treated cancer patient...
Novavax Announces Early Retirement of $17 Million of Convertible Debt
Transaction removes significant financial obligation and improves balance sheet
ROCKVILLE, Md., April 29 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX ), a leader in the development of novel vaccines, today announced that it has reached an early
payoff agreement with holders of $17 ...
PAREXEL Experts to Address Benefits of Rigorous Early Phase Development at Annual ASCPT Meeting
BOSTON, March 16 /PRNewswire/ -- PAREXEL experts will address the benefits of rigorous early
phase clinical development at the 110th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics (ASCPT), to be held at the Gaylord National Resort in National Harbor, Maryland fro...
Covance Increases Early Clinical Footprint in Europe with Acquisition of Swiss-Based Early Clinical Development Site
PRINCETON, N.J., March 13 /PRNewswire-FirstCall/ -- Covance Inc. (NYSE: CVD ) announced today that it is expanding its clinical pharmacology footprint in Europe with the acquisition of Swiss Pharma Contract, a 50-bed clinical research company based in Basel, Switzerland.
"Our clients' need ...
Further 100 Million Euros Allocated to Netherlands-Based R&D Targeting the Early Diagnosis and Treatment of Disease
EINDHOVEN, The Netherlands, March 10 /PRNewswire/ -- The Center for
Translational Molecular Medicine (CTMM) - the Dutch public-private
partnership committed to the research and development of new techniques for
the diagnosis and treatment of major diseases - today announced that eight
Index Ventures Closes Euro 350 Million Early Stage Fund
Ben Holmes Named Partner
LONDON, March 3 /PRNewswire/ -- Index Ventures today announced the closing of a euro 350 million early
stage fund, Index Ventures V. The fund is dedicated to early
stage and seed investments in the technology, biotechnology and clean technology sectors across Europ...
Frost & Sullivan Forecasts Early Rebound: Strong Growth Ahead for Global Economy
MOUNTAIN VIEW, Calif., Feb. 17 /PRNewswire/ -- Frost & Sullivan, the
Growth Partnership Company, reaffirms its position that the economy is
regaining its strength, thanks in part to an unprecedented US $1 trillion
stimulus package from the US government and additional stimulus packages fro...
SMU chemist wins NSF early career award
DALLAS -- Southern Methodist University chemist Brent Sumerlin has earned a National Science Foundation Faculty Early
Career Development Award, given to junior faculty members who exemplify the role of teacher-scholars in American colleges and universities.
Sumerlin, assistant professor in the ...
Cryoablation of Early Invasive Ductal Breast Cancer With MRI Confirmation Shows Promising Clinical Benefits, According to Study Presented at RSNA
CHICAGO, Dec. 5 /PRNewswire/ -- Early
clinical experience with the FDA
cleared Visica 2(TM) Treatment System from Sanarus Medical confirms the
effectiveness of ultrasound guided cryoablation to completely eradicate
small, unifocal Invasive Ductal Breast Cancer (IDC). Initial data from this
RVX-208 Exploratory Study Illustrates Early Potential for Alzheimer's Disease
First in class drug illustrates early
signal of transport of key amyloid marker from brain
TSX Exchange Symbol: RVX CALGARY, Nov. 10 /PRNewswire-FirstCall/ - Resverlogix Corp.
("Resverlogix") (TSX:RVX) announced today that treatment with its lead drug
RVX-208, a first in class ApoA-I/Prebet...
BSP Signs Agreement With CMP Trading for Distribution of HyperQ(TM) Stress System, for Early Detection of Ischemic Heart Disease, in South Korea
CMP Will Purchase at Least 227 HyperQ(TM) Systems During the Term of the Agreement
TEL AVIV, Israel, November 10 /PRNewswire-FirstCall/ -- BSP (Biological
Signal Processing Ltd.) ( http://www.bsp.co.il/ ), an Israeli company that
develops and markets innovative sy...
Chiltern Early Phase: Fully Integrated and Business Ready
LONDON, Aug. 27 /PRNewswire/ -- Following the successful acquisition of
Drug Development Solutions ('DDS') in February, Chiltern, a leading
contract research organization, announced today that it has fully
integrated its two early
Phase units into a single operation branded as
Chest Physicians Now Suggest Early Intervention for Certain Blood Clots in DVT
2008 American College of Chest Physicians (ACCP) Guidelines Will Increase Use of Trellis(R) Peripheral Infusion System
NORTHBROOK, Ill., July 29 /PRNewswire/ -- The American College of Chest
Physicians (ACCP) has published new evidence-based clinical guidelines for
physicians that ...
Nano-sized electronic circuit promises bright view of early universe
NEW BRUNSWICK, N.J. A newly developed nano-sized electronic device is an important step toward helping astronomers see invisible light dating from the creation of the universe. This invisible light makes up 98% of the light emitted since the "big bang," and may provide insights into the earliest ...
New MedPredict Report Highlights Trend Toward Early Diagnosis and Treatment of Rheumatoid Arthritis, Impact on Pharmaceutical Development
SCOTTSDALE, Ariz., July 8 /PRNewswire/ -- MedPredict Market Research, a
global provider of pharmaceutical competitive intelligence and market
research, has published a new report providing critical strategic insight
for pharma and biotech companies with a stake in the market for Rheumatoid
Dow AgroSciences Announces Early Exercise of Option for Commercial License With Sangamo BioSciences for Plants
Dow AgroSciences Will Sublicense Sangamo's Technology in Plant Agriculture Under the Trademark EXZACT(TM) Precision Traits
SAN DIEGO, June 18 /PRNewswire-FirstCall/ -- Dow AgroSciences LLC, a
wholly owned subsidiary of The Dow Chemical Company (NYSE: DOW ), announced
today at the 20...
PAREXEL Enhances Early Phase Clinical Development Offering for Central Nervous System Studies
BOSTON, June 17 /PRNewswire-FirstCall/ -- PAREXEL International
Corporation (Nasdaq: PRXL ), a leading global biopharmaceutical services
provider, today announced that it is expanding its clinical pharmacology
capabilities in the Central Nervous System (CNS) therapeutic area. PAREXEL
First semiconductor-based PET scanner demonstrates potential to aid in early diagnosis of disease
NEW ORLEANS, La.Evaluations of the first-ever prototype positron emission tomography (PET) brain scanner that uses semiconductor detectors indicate that the scanner could advance the quality and spatial resolution of PET imaging, according to researchers at SNM's 55th Annual Meeting. The prototype...
Video: Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia
- Efficacy and safety profile in large randomized Phase III study
consistent with landmark IRIS trial, which established Gleevec as standard of care
- Study did not meet primary endpoint at 1 year, yet shows faster time to molecular responses with...
First Taxane-Based Non-Anthracycline Containing Chemotherapy in Combination With Herceptin (TCH) for HER2 Positive Early Breast Cancer Patients Obtains Approval From the FDA
TCH (Taxotere, Carboplatin, Herceptin) showed a significant improvement in
Disease-Free Survival (DFS) and Overall Survival (OS), compared to AC-T
(doxorubicin and cyclophosphamide followed by docetaxel) and a 5-fold lower
cardiotoxicity compared to AC-TH (AC-T + Herceptin) in women receivin...
Genetic Engineering and Biotechnology News (GEN) Reports on Early ADMET Use
NEW ROCHELLE, N.Y., May 5 /PRNewswire/ -- Biotech and pharma companies
are increasingly utilizing novel technologies to assess the druggability of
test compounds early
in the development cycle to avoid costly late
clinical-stage attrition, according to Genetic Engineering and
Increased Light Leads to Early Detection: Caliper Life Sciences Introduces Bioware(R) Ultra Cancer Cell Lines
-Researchers Now Able to Detect a Single Cancer Cell Through In Vivo Imaging-
HOPKINTON, Mass., April 15 /PRNewswire-FirstCall/ -- Caliper Life
Sciences, Inc. (Nasdaq: CALP ) today introduced Bioware(R) Ultra cell lines,
a range of ultra bright light producing...
Canadian Centre for DNA Barcoding to Participate in Microchip Biotechnologies Early Access Program for Microchip-Based DNA Sample Preparation and Cycle Sequencing
DUBLIN, Calif., April 8, 2008 /PRNewswire/ -- Microchip
Biotechnologies, Inc. (MBI) is pleased to announce that the Canadian Centre
for DNA Barcoding (CCDB), at the Biodiversity Institute of Ontario,
University of Guelph, will be the first participant to join MBI's early
access program for the...
JCI online early table of contents: March 6, 2008
EDITOR'S PICK: Pinpoint accuracy: DNA vaccines that home in on DCs are more potent
One strategy being pursued to develop new vaccines against infectious diseases is DNA vaccination. The idea is that following administration of a DNA vaccine, the body converts the information in the DNA vaccin...
New Independent Research Study Indicates That Cylex's ImmuKnow Test May Identify Kidney Transplant Patients at Risk for Early Acute Rejection
COLUMBIA, Md., Feb. 20 /PRNewswire/ -- Cylex, Inc., today announced the
publication of an independent, peer reviewed, clinical research study in
which the level of cellular immune response measured prior to kidney
transplantation using the Company's proprietary ImmuKnow(R) immune cell
Campbell Alliance Brand Management and Managed Markets Practices to Speak at CBI's Early Commercialization Conference
RALEIGH, N.C., Feb. 19 /PRNewswire/ -- Campbell Alliance, the leading
management consulting firm specializing in the pharmaceutical and biotech
industry, today announced that executives from its Brand Management and
Managed Markets practices will present at the 4th Annual Forum on Early
New Technology for Early Detection of Lung Cancer Selected for Clinical Study With Veterans
New Mexico Department of Veterans Services Partners with New Mexico Tech and Biomoda, Inc.
ALBUQUERQUE, N.M., Feb. 14 /PRNewswire-FirstCall/ -- The New Mexico
Institute of Mining and Technology (New Mexico Tech) and Biomoda, Inc. (OTC
Bulletin Board: BMOD) (http://ww...
Biomoda and Medical Acoustics Partner in Study for Early Detection of Lung Cancer in Veterans
Innovative Lung Flute(R) to be used to provide cost-efficient, easy to use method of collecting lung sputum samples for testing
ALBUQUERQUE, N.M., Feb. 13 /PRNewswire-FirstCall/ -- Biomoda, Inc. (OTC
Bulletin Board: BMOD), a maker of patented early
lung cancer detection
testing and oth...
Solstice Neurosciences, Inc. Issues Corporate Response to FDA Early Communication
MALVERN, Pa., Feb. 8 /PRNewswire/ -- Safety of patients treated with
Myobloc(R) (Botulinum Toxin Type B) Injectable Solution has always been of
primary importance for Solstice Neurosciences, Inc. ("Solstice"). We
support education and training of physicians in a number of ways regarding
Montana State University lab gives early warnings about biological invaders
BOZEMAN, Mont. -- Montanans don't think a lot about "Homeland Security," but one Montana State University unit that serves both ag producers and home gardeners also serves to keep us safe from other biological invaders.
The Schutter Diagnostic Lab on the Bozeman campus recently received a five-...
Medicsight Welcomes U.S. Initiative to Reimburse CT Colonography for Early Detection of Colorectal Cancer
NEW YORK, Dec. 21 /PRNewswire-FirstCall/ -- Medicsight PLC, a
subsidiary of MGT Capital Investments, Inc. (Amex: MGT ), and an industry
leader in the development of Computer-Aided Detection (CAD) and image
analysis software which assists in the early
detection of disease, welcomes
DermTech Is Issued U.S. Patent for the Early Detection, Staging and Monitoring of Melanoma
LA JOLLA, Calif., Dec 19 /PRNewswire/ -- DermTech, Inc., a
biotechnology company developing molecular diagnostics for the early
detection of melanoma and other diseases, announced that it has been issued
Patent No. 7,297,480 by the United States Patent and Trademark Office. The
A&G Pharmaceutical Receives $870,000 Grant from Avon Foundation to Advance Innovative Blood Diagnostic Test for Early Detection of Breast Cancer
COLUMBIA, Md., Dec. 14 /PRNewswire/ -- A&G Pharmaceutical announced
today that the Avon Foundation Breast Cancer Prevention Research Initiative
has awarded A&G an $870,000 grant to conduct multicenter clinical studies
focused on measuring levels of A&G's proprietary breast cancer biomarker,
Multigene Test Predicts Who Could Avoid Chemotherapy Despite Positive Lymph Nodes in Early Breast Cancer
SAN ANTONIO, Texas, Dec. 13 /PRNewswire/ -- Kathy S. Albain, MD, of
Loyola University Chicago, presented new data showing for the first time
the predictive value of the 21-gene Recurrence Score (RS) assay in patients
with node-positive breast cancer. The Breast Cancer Intergroup of North
Taxotere(R)-Based Chemotherapy Significantly Improved Overall Survival Compared With Standard Anthracycline-Based Chemotherapy in Early Stage Breast Cancer
Oral Presentation of the US Oncology Adjuvant Trial 9735 at 2007 San
Antonio Breast Cancer Symposium Showed Taxotere(R) and Cyclophosphamide Improved Overall Survival Versus An Anthracycline Combination
SAN ANTONIO, Dec. 13 /PRNewswire-FirstCall/ -- Results presented at the
The Tauri Group LLC Awarded U.S. Department of Homeland Security Chemical and Biological Early Detection Systems Program Office Support Contract
ALEXANDRIA, Va., Dec. 11 /PRNewswire/ -- The Tauri Group LLC is pleased
to announce that it has been selected to provide Systems Engineering and
Technical Assistance (SETA) support for the U.S. Department of Homeland
Security (DHS) Office of Health Affairs Early
Detection Division Chemical
New technique can be breakthrough for early cancer diagnosis Early
detection of disease is often critical to how successful treatment can be. Therefore, the development of new methods of diagnosis is a hot research field, where every small step is of great importance. In an article in the latest issue of Molecular & Cellular Proteomics, Uppsala University...